Core Laboratories NV (CLB)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024
Cash and cash equivalents	US$ in thousands	19,157	21,474	17,695	14,913
Short-term investments	US$ in thousands	—	—	—	—
Total current liabilities	US$ in thousands	97,586	94,938	97,598	85,468
Cash ratio		0.20	0.23	0.18	0.17

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($19,157K + $—K) ÷ $97,586K
= 0.20

The cash ratio is a liquidity ratio that measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to meet short-term obligations.

Based on the data provided for Core Laboratories NV:
- As of March 31, 2024, the cash ratio was 0.17, indicating that the company had $0.17 in cash and cash equivalents for every $1 of current liabilities.
- The cash ratio improved to 0.18 as of June 30, 2024, suggesting a slight increase in the company's ability to cover its short-term obligations.
- By September 30, 2024, the cash ratio further improved to 0.23, indicating a more favorable liquidity position for Core Laboratories NV.
- However, the cash ratio decreased to 0.20 as of December 31, 2024, showing a slight decrease in the company's ability to meet short-term liabilities compared to the previous quarter.

Overall, Core Laboratories NV demonstrated varying levels of liquidity throughout the year, with the September 30, 2024, ratio being the highest. It is important for the company to maintain a healthy cash ratio to ensure it can meet its short-term financial obligations effectively.